世界のループス治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lupus Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3498 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ループス治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B細胞モジュレーター、T細胞モジュレーター、免疫抑制剤・細胞毒性薬、炎症誘発性・サイトカイン阻害剤、その他）、用途別市場規模（クリニック、病院、医師オフィス研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ループス治療の市場動向 ・企業の競争状況、市場シェア ・ループス治療の種類別市場規模（B細胞モジュレーター、T細胞モジュレーター、免疫抑制剤・細胞毒性薬、炎症誘発性・サイトカイン阻害剤、その他） ・ループス治療の用途別市場規模（クリニック、病院、医師オフィス研究所） ・ループス治療の北米市場規模2016-2027（アメリカ、カナダ） ・ループス治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ループス治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ループス治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ループス治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F.Hoffmann-La Roche、GlaxoSmithKline、Medlmmune、Pfizer、ADMA Biologics、Amgen、Anthera Pharmaceuticals、Bayer HealthCare、Biogen） ・結論

Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition.
According to the report, one of the major drivers for this market is high prevalence rate.

Market Analysis and Insights: Global Lupus Therapeutic Market
The global Lupus Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lupus Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lupus Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lupus Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lupus Therapeutic market.

Global Lupus Therapeutic Scope and Market Size
Lupus Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lupus Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
B-Cell Modulators
T-Cell Modulators
Immunosuppressive And Cytotoxic Drugs
Proinflammatory And Cytokine Inhibitors
Others

Segment by Application
Clinics
Hospitals
Physicians’ Office Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F.Hoffmann-La Roche
GlaxoSmithKline
Medlmmune
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer HealthCare
Biogen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lupus Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 B-Cell Modulators
1.2.3 T-Cell Modulators
1.2.4 Immunosuppressive And Cytotoxic Drugs
1.2.5 Proinflammatory And Cytokine Inhibitors
1.2.6 Others
1.3 Market by Application
1.3.1 Global Lupus Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Physicians’ Office Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lupus Therapeutic Market Perspective (2016-2027)
2.2 Lupus Therapeutic Growth Trends by Regions
2.2.1 Lupus Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lupus Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Lupus Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Lupus Therapeutic Industry Dynamic
2.3.1 Lupus Therapeutic Market Trends
2.3.2 Lupus Therapeutic Market Drivers
2.3.3 Lupus Therapeutic Market Challenges
2.3.4 Lupus Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lupus Therapeutic Players by Revenue
3.1.1 Global Top Lupus Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Lupus Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Lupus Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lupus Therapeutic Revenue
3.4 Global Lupus Therapeutic Market Concentration Ratio
3.4.1 Global Lupus Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lupus Therapeutic Revenue in 2020
3.5 Lupus Therapeutic Key Players Head office and Area Served
3.6 Key Players Lupus Therapeutic Product Solution and Service
3.7 Date of Enter into Lupus Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lupus Therapeutic Breakdown Data by Type
4.1 Global Lupus Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Lupus Therapeutic Forecasted Market Size by Type (2022-2027)

5 Lupus Therapeutic Breakdown Data by Application
5.1 Global Lupus Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Lupus Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lupus Therapeutic Market Size (2016-2027)
6.2 North America Lupus Therapeutic Market Size by Type
6.2.1 North America Lupus Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Lupus Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Lupus Therapeutic Market Size by Type (2016-2027)
6.3 North America Lupus Therapeutic Market Size by Application
6.3.1 North America Lupus Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Lupus Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Lupus Therapeutic Market Size by Application (2016-2027)
6.4 North America Lupus Therapeutic Market Size by Country
6.4.1 North America Lupus Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Lupus Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Lupus Therapeutic Market Size (2016-2027)
7.2 Europe Lupus Therapeutic Market Size by Type
7.2.1 Europe Lupus Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Lupus Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Lupus Therapeutic Market Size by Type (2016-2027)
7.3 Europe Lupus Therapeutic Market Size by Application
7.3.1 Europe Lupus Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Lupus Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Lupus Therapeutic Market Size by Application (2016-2027)
7.4 Europe Lupus Therapeutic Market Size by Country
7.4.1 Europe Lupus Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Lupus Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lupus Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Lupus Therapeutic Market Size by Type
8.2.1 Asia-Pacific Lupus Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lupus Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lupus Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Lupus Therapeutic Market Size by Application
8.3.1 Asia-Pacific Lupus Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lupus Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lupus Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Lupus Therapeutic Market Size by Region
8.4.1 Asia-Pacific Lupus Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lupus Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lupus Therapeutic Market Size (2016-2027)
9.2 Latin America Lupus Therapeutic Market Size by Type
9.2.1 Latin America Lupus Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Lupus Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Lupus Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Lupus Therapeutic Market Size by Application
9.3.1 Latin America Lupus Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Lupus Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Lupus Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Lupus Therapeutic Market Size by Country
9.4.1 Latin America Lupus Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Lupus Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lupus Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Lupus Therapeutic Market Size by Type
10.2.1 Middle East & Africa Lupus Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lupus Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lupus Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Lupus Therapeutic Market Size by Application
10.3.1 Middle East & Africa Lupus Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lupus Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lupus Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Lupus Therapeutic Market Size by Country
10.4.1 Middle East & Africa Lupus Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lupus Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F.Hoffmann-La Roche
11.1.1 F.Hoffmann-La Roche Company Details
11.1.2 F.Hoffmann-La Roche Business Overview
11.1.3 F.Hoffmann-La Roche Lupus Therapeutic Introduction
11.1.4 F.Hoffmann-La Roche Revenue in Lupus Therapeutic Business (2016-2021)
11.1.5 F.Hoffmann-La Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Lupus Therapeutic Introduction
11.2.4 GlaxoSmithKline Revenue in Lupus Therapeutic Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Medlmmune
11.3.1 Medlmmune Company Details
11.3.2 Medlmmune Business Overview
11.3.3 Medlmmune Lupus Therapeutic Introduction
11.3.4 Medlmmune Revenue in Lupus Therapeutic Business (2016-2021)
11.3.5 Medlmmune Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Lupus Therapeutic Introduction
11.4.4 Pfizer Revenue in Lupus Therapeutic Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 ADMA Biologics
11.5.1 ADMA Biologics Company Details
11.5.2 ADMA Biologics Business Overview
11.5.3 ADMA Biologics Lupus Therapeutic Introduction
11.5.4 ADMA Biologics Revenue in Lupus Therapeutic Business (2016-2021)
11.5.5 ADMA Biologics Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Lupus Therapeutic Introduction
11.6.4 Amgen Revenue in Lupus Therapeutic Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Company Details
11.7.2 Anthera Pharmaceuticals Business Overview
11.7.3 Anthera Pharmaceuticals Lupus Therapeutic Introduction
11.7.4 Anthera Pharmaceuticals Revenue in Lupus Therapeutic Business (2016-2021)
11.7.5 Anthera Pharmaceuticals Recent Development
11.8 Bayer HealthCare
11.8.1 Bayer HealthCare Company Details
11.8.2 Bayer HealthCare Business Overview
11.8.3 Bayer HealthCare Lupus Therapeutic Introduction
11.8.4 Bayer HealthCare Revenue in Lupus Therapeutic Business (2016-2021)
11.8.5 Bayer HealthCare Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Lupus Therapeutic Introduction
11.9.4 Biogen Revenue in Lupus Therapeutic Business (2016-2021)
11.9.5 Biogen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lupus Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of B-Cell Modulators
Table 3. Key Players of T-Cell Modulators
Table 4. Key Players of Immunosuppressive And Cytotoxic Drugs
Table 5. Key Players of Proinflammatory And Cytokine Inhibitors
Table 6. Key Players of Others
Table 7. Global Lupus Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lupus Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Lupus Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Lupus Therapeutic Market Share by Regions (2016-2021)
Table 11. Global Lupus Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Lupus Therapeutic Market Share by Regions (2022-2027)
Table 13. Lupus Therapeutic Market Trends
Table 14. Lupus Therapeutic Market Drivers
Table 15. Lupus Therapeutic Market Challenges
Table 16. Lupus Therapeutic Market Restraints
Table 17. Global Lupus Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Lupus Therapeutic Market Share by Players (2016-2021)
Table 19. Global Top Lupus Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lupus Therapeutic as of 2020)
Table 20. Ranking of Global Top Lupus Therapeutic Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Lupus Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lupus Therapeutic Product Solution and Service
Table 24. Date of Enter into Lupus Therapeutic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lupus Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Lupus Therapeutic Revenue Market Share by Type (2016-2021)
Table 28. Global Lupus Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Lupus Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Lupus Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Lupus Therapeutic Revenue Market Share by Application (2016-2021)
Table 32. Global Lupus Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Lupus Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Lupus Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Lupus Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Lupus Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Lupus Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Lupus Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Lupus Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Lupus Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Lupus Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Lupus Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Lupus Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Lupus Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Lupus Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Lupus Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Lupus Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Lupus Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Lupus Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Lupus Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Lupus Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Lupus Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Lupus Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Lupus Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Lupus Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Lupus Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Lupus Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Lupus Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Lupus Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Lupus Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Lupus Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Lupus Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Lupus Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 64. F.Hoffmann-La Roche Company Details
Table 65. F.Hoffmann-La Roche Business Overview
Table 66. F.Hoffmann-La Roche Lupus Therapeutic Product
Table 67. F.Hoffmann-La Roche Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 68. F.Hoffmann-La Roche Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Lupus Therapeutic Product
Table 72. GlaxoSmithKline Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Medlmmune Company Details
Table 75. Medlmmune Business Overview
Table 76. Medlmmune Lupus Therapeutic Product
Table 77. Medlmmune Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 78. Medlmmune Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Lupus Therapeutic Product
Table 82. Pfizer Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. ADMA Biologics Company Details
Table 85. ADMA Biologics Business Overview
Table 86. ADMA Biologics Lupus Therapeutic Product
Table 87. ADMA Biologics Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 88. ADMA Biologics Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Lupus Therapeutic Product
Table 92. Amgen Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. Anthera Pharmaceuticals Company Details
Table 95. Anthera Pharmaceuticals Business Overview
Table 96. Anthera Pharmaceuticals Lupus Therapeutic Product
Table 97. Anthera Pharmaceuticals Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 98. Anthera Pharmaceuticals Recent Development
Table 99. Bayer HealthCare Company Details
Table 100. Bayer HealthCare Business Overview
Table 101. Bayer HealthCare Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 102. Bayer HealthCare Recent Development
Table 103. Biogen Company Details
Table 104. Biogen Business Overview
Table 105. Biogen Lupus Therapeutic Product
Table 106. Biogen Revenue in Lupus Therapeutic Business (2016-2021) & (US$ Million)
Table 107. Biogen Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lupus Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. B-Cell Modulators Features
Figure 3. T-Cell Modulators Features
Figure 4. Immunosuppressive And Cytotoxic Drugs Features
Figure 5. Proinflammatory And Cytokine Inhibitors Features
Figure 6. Others Features
Figure 7. Global Lupus Therapeutic Market Share by Application: 2020 VS 2027
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Physicians' Office Laboratories Case Studies
Figure 11. Lupus Therapeutic Report Years Considered
Figure 12. Global Lupus Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Lupus Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Lupus Therapeutic Market Share by Regions: 2020 VS 2027
Figure 15. Global Lupus Therapeutic Market Share by Regions (2022-2027)
Figure 16. Global Lupus Therapeutic Market Share by Players in 2020
Figure 17. Global Top Lupus Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lupus Therapeutic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Lupus Therapeutic Revenue in 2020
Figure 19. Global Lupus Therapeutic Revenue Market Share by Type (2016-2021)
Figure 20. Global Lupus Therapeutic Revenue Market Share by Type (2022-2027)
Figure 21. North America Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Lupus Therapeutic Market Share by Type (2016-2027)
Figure 23. North America Lupus Therapeutic Market Share by Application (2016-2027)
Figure 24. North America Lupus Therapeutic Market Share by Country (2016-2027)
Figure 25. United States Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Lupus Therapeutic Market Share by Type (2016-2027)
Figure 29. Europe Lupus Therapeutic Market Share by Application (2016-2027)
Figure 30. Europe Lupus Therapeutic Market Share by Country (2016-2027)
Figure 31. Germany Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Lupus Therapeutic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Lupus Therapeutic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Lupus Therapeutic Market Share by Region (2016-2027)
Figure 41. China Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Lupus Therapeutic Market Share by Type (2016-2027)
Figure 49. Latin America Lupus Therapeutic Market Share by Application (2016-2027)
Figure 50. Latin America Lupus Therapeutic Market Share by Country (2016-2027)
Figure 51. Mexico Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Lupus Therapeutic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Lupus Therapeutic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Lupus Therapeutic Market Share by Country (2016-2027)
Figure 57. Turkey Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Lupus Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F.Hoffmann-La Roche Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 62. Medlmmune Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 64. ADMA Biologics Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 66. Anthera Pharmaceuticals Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 67. Bayer HealthCare Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 68. Biogen Revenue Growth Rate in Lupus Therapeutic Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---